Your browser doesn't support javascript.
loading
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal, Amira A; Brewer, Rachel E; Markovic, Maxim; Kowarsky, Mark; Barkal, Sammy A; Zaro, Balyn W; Krishnan, Venkatesh; Hatakeyama, Jason; Dorigo, Oliver; Barkal, Layla J; Weissman, Irving L.
  • Barkal AA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Brewer RE; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Markovic M; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Kowarsky M; Stanford Medical Scientist Training Program, Stanford University, Stanford, CA, USA.
  • Barkal SA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Zaro BW; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Krishnan V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Hatakeyama J; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Dorigo O; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Barkal LJ; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Weissman IL; Department of Physics, Stanford University, Stanford, CA, USA.
Nature ; 572(7769): 392-396, 2019 08.
Article en En | MEDLINE | ID: mdl-31367043

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transducción de Señal / Receptores de Superficie Celular / Antígeno CD24 / Antineoplásicos Inmunológicos / Inmunoterapia / Lectinas / Macrófagos / Neoplasias Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transducción de Señal / Receptores de Superficie Celular / Antígeno CD24 / Antineoplásicos Inmunológicos / Inmunoterapia / Lectinas / Macrófagos / Neoplasias Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article